WHO Guideline: Summary of Recommendations on Pharmaceutical Pricing Policies

How will the new WHO recommendations on pharmaceutical pricing policies affect your organization?

Multimedia
Published on:
November 2, 2020

The WHO recently launched a series of recommendations on pharmaceutical pricing policies to help countries make medicines more affordable for the global population and lessen the burden on government budgets.

Alira Health’s Nerea Blanque-Catalina, VP, Market Access & Pricing, and Luis Culla, Associate Director, Global Market Access, dive into these new recommendations and provide advice on how companies can manage the impact of these new guidelines.

For more information and to connect with the team, contact us here.

Listen to our podcast: Alira Health’s Transformation Talks

In this episode we talk about the above-mentioned updated WHO Guideline with our insight industry experts calling from around the globe, Omar Ali, Lecturer Value-Based Pricing and Outcomes Based Innovative Contracting and Former Member Adoption and Impact Panel at NICE, and Oscar Pérez Albet, Chief Business Development and Global Alliances Officer, and our Alira Health hosts  Kenny Carberry, Associate Director, Clinical Development, and NereaBlanqué-Catalina, VP, Market Access & Pricing.

WHO Guideline: Summary of Recommendations on Pharmaceutical Pricing Policies

Report Download

Related news

Digital Health Market Access
Publications April 20, 2021
Health Economics Evaluation and Value Proposition for an Antimicrobial Medical Device in the U.S. Market
A health economics evaluation assists companies during product development to better understand the product's impact across the ecosystem and position it appropriately.
Due Diligence MedTech Patient Engagement Pharma
Multimedia April 12, 2021
Evolution of the Drug Delivery Systems Industry and its Increasing Role in Driving Patient Outcomes
In the third episode, Amira Ghozali, Aptar Pharma, Kenny Carberry, and Aude Ouensanga, discuss the evolution of the DDS industry, its relationship with Pharma, and its increasing role(...)
Market Access MedTech
Multimedia February 26, 2021
Pricing in MedTech: Disentangling the Roles of Payers, DRGs, and Procurement
Join host Kenny Carberry, Associate Director of Clinical Development, Dan Legg, former Director of Clinical Sourcing at Guy’s & St Thomas at the St Thomas Hospital in London and CEO(...)
MedTech Pharma
Publications February 8, 2021
Infographic: 2021 Trends in Healthcare
It is no secret that the COVID-19 pandemic has presented new challenges for businesses, and virtual has become the ‘new normal’, including for transactions.
MedTech Pharma
News February 4, 2021
2020 Year in Review
With 2021 in full swing, we want to take a moment to reflect on last year’s achievements and congratulate the entire Alira Health Team for their hard work and dedication to healthcare(...)
M&A Pharma
News December 20, 2020
We Announce our role as Strategic Advisor to Mérieux Equity Partners and Mérieux Participations 3 for Entering the Capital of CTRS
We are pleased to announce our role as strategic advisor to Mérieux Equity Partners as they join the Series A financing round of Cell-Easy, through Mérieux’s newly established venture fund, OMX.
Pharma
News December 15, 2020
Welcome Daniela Sica, Vice President, Business Development, Pharma and Biotech
We are pleased to announce that Daniela Sica has joined the firm as Vice President, Business Development, Pharma and Biotech.

Our locations around the globe

Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.